clindamycin phosphate · Padagis Us · NDA 050793
Clindesse
Earliest generic entry, as listed
2 Dec 2026
Blocked by patent: US 9789057.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9789057 | drug product, use U-137 · sets the listed date | 2 Dec 2026 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Enters 12-month window basis: patent · 050793-001Listed date 2 Dec 2026Detected 24 Oct 2026
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 050793 · 001 · RLD | cream, vaginal | EQ 2% BASE | 2 Dec 2026 |